Nebraska Administrative Code
Topic - HEALTH AND HUMAN SERVICES SYSTEM
Title 471 - NEBRASKA MEDICAL ASSISTANCE PROGRAM SERVICES
Chapter 16 - PHARMACY SERVICES
Section 471-16-002 - DRUG UTILIZATION REVIEW

Current through September 17, 2024

As a condition of participation, the provider is required to:

(A) Provide prospective drug utilization review before dispensing each prescription. This includes screening for:

(i) Therapeutic duplication:

(ii) Drug disease contraindications:

(iii) Drug interactions:

(iv) Incorrect dosage or duration:

(v) Drug allergies: and

(vi) Clinical abuse and misuse:

(B) Provide patient counseling on all matters which, in the provider's professional judgment are deemed significant, including:

(i) Name and description of the medication:

(ii) Route, dosage form, duration of therapy;

(iii) Directions for use;

(iv) Adverse reactions, contraindications:

(v) Storage: and

(vi) Refill information: and

(C) Maintain adequate patient profiles which may include:

(i) Name, address, phone number, date of birth, and gender;

(ii) individual history;

(iii) Comprehensive listing of medications: and

(iv) Relevant comments.

Disclaimer: These regulations may not be the most recent version. Nebraska may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.